Leukocyte Interleukin, Injection 200IU
NMCSD.2013.0080
Phase 1 small_molecule terminated
Quick answer
Leukocyte Interleukin, Injection 200IU for Condyloma is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Condyloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated